Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avelumab plus Gemcitabine in Advanced Leiomyosarcoma
NCT03536780Phase 2Unknown
- Sponsor
- Gachon University Gil Medical Center
- Start
- Oct 2018
- Primary completion
- Dec 2021
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of avelumab in leiomyosarcoma (LMS), sponsored by Gachon University Gil Medical Center. Status: unknown.
02
Drugs
avelumab
03
Conditions
leiomyosarcoma (LMS)
Beyond the preview
Go deeper on NCT03536780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03536780.